ImThera Medical

About:

ImThera is a medical device company that has developed a neurostimulation implant for the treatment of Obstructive Sleep Apnea.

Website: http://www.imtheramedical.com

Twitter/X: imthera

Top Investors: Cyberonics

Description:

ImThera Medical is a San Diego, California based medical device company. The company’s mission is to help Obstructive Sleep Apnea (OSA) patients live longer and enjoy better lives while substantially reducing the health care costs related to the serious complications associated with OSA. ImThera's sleep apnea implant is based on neurostimulation technology, delivering muscle tone to key tongue muscles during sleep, hence opening the upper airway and substantially reducing or eliminating OSA events. An estimated 28 million Americans suffer from OSA and while CPAP is the established therapy, studies show that less than 50% of patients comply with CPAP therapy. ImThera's THN Sleep Therapy System is a proprietary therapeutic solution that promises an exciting, new era in sleep apnea treatment. www.ImTheraMedical.com.

Total Funding Amount:

$17.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2007-01-01

Contact Email:

contact(AT)imtheramedical.com

Founders:

Marcelo Lima

Number of Employees:

11-50

Last Funding Date:

2015-11-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai